Science Explorer Back to mapMap
Discussion
Topic · Biomaterials

Nanoparticle-Based Drug Delivery

Nanoparticle-Based Drug Delivery is a research topic within Biomaterials. Science Explorer counts 48k research works in it since 1951. 9.8% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the development and application of nanoparticle-based drug delivery systems, particularly for cancer therapy. It covers topics such as nanocarriers, surface engineering of nanoparticles, magnetic nanoparticles, tumor targeting, polymeric nanoparticles, and the enhanced permeability and retention (EPR) effect. The research explores the synthesis, functionalization, and biomedical applications of various types of nanoparticles for drug delivery.

  • Nanocarriers
  • Drug Delivery
  • Nanoparticles
  • Cancer Therapy
  • Surface Engineering
  • Magnetic Nanoparticles
  • Biomedical Applications
  • Tumor Targeting
  • Polymeric Nanoparticles
  • EPR Effect
Research works
48k
fractional, since 1951
In the world top 10%
4.7k
per year above
Top-10% rate
9.8%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+15%
the tick is no change
Largest producer
China
40% of the 10 largest, 2022-now
Nanoparticle-Based Drug Delivery

Which countries lead Nanoparticle-Based Drug Delivery research?

By volume, China and India publish the most (4k and 2.3k works in 2022-now).

By volume, 2022-now

  1. 1 China 4k works
  2. 2 India 2.3k works
  3. 3 United States 1.2k works
  4. 4 Iran 737 works
  5. 5 South Korea 320 works
  6. 6 Italy 288 works
  7. 7 Russia 276 works
  8. 8 Türkiye 270 works
  9. 9 Japan 260 works
  10. 10 Germany 247 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 40.2%India: 23.3%United States: 12.4%Iran: 7.4%6 others listed: 16.7%40%largest
China3,993 · 40.2%India2,312 · 23.3%United States1,231 · 12.4%Iran737 · 7.4%6 others listed1,662 · 16.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Nanoparticle-Based Drug Delivery research?

By volume in 2022-now, Chinese Academy of Sciences publishes the most Nanoparticle-Based Drug Delivery research, followed by Sichuan University and Islamic Azad University, Tehran.

By volume, 2022-now

  1. 1 Chinese Academy of SciencesChina 165 works
  2. 2 Sichuan UniversityChina 107 works
  3. 3 Islamic Azad University, TehranIran 104 works
  4. 4 Centre National de la Recherche ScientifiqueFrance 97 works
  5. 5 Russian Academy of SciencesRussia 96 works
  6. 6 Shanghai Jiao Tong UniversityChina 83 works
  7. 7 Zhejiang UniversityChina 78 works
  8. 8 Sun Yat-sen UniversityChina 68 works
  9. 9 Shenyang Pharmaceutical UniversityChina 61 works
  10. 10 Fudan UniversityChina 56 works

Who are the leading researchers in Nanoparticle-Based Drug Delivery?

The most-cited researchers publishing on Nanoparticle-Based Drug Delivery include Bert Vogelstein, Yury G. Gogotsi and Róbert Langer.

  1. 1 Bert Vogelstein United States 373k citations
  2. 2 Yury G. Gogotsi United States 313k citations
  3. 3 Róbert Langer United States 303k citations
  4. 4 Hagop M. Kantarjian United States 273k citations
  5. 5 Wei Huang China 267k citations
  6. 6 Charles M. Perou United States 263k citations
  7. 7 Ben Zhong Tang China 261k citations
  8. 8 Amirhossein Sahebkar Iran 258k citations
  9. 9 Valentı́n Fuster United States 257k citations
  10. 10 Kenneth W. Kinzler United States 253k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Nanoparticle-Based Drug Delivery?

The most cited paper in Nanoparticle-Based Drug Delivery is "Nanocarriers as an emerging platform for cancer therapy" (Dan Peer, Jeffrey M. Karp, Seungpyo Hong et al., 2007), with 8,681 citations. Next come "Engineering precision nanoparticles for drug delivery" (7,854) and "Understanding biophysicochemical interactions at the nano–bio interface" (7,073).

Most cited papers
#PaperReleasedCitations
1 Nanocarriers as an emerging platform for cancer therapy Dan Peer, Jeffrey M. Karp, Seungpyo Hong et al. · Nature Nanotechnology Dec 2007 8,681
2 Engineering precision nanoparticles for drug delivery Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley et al. · Nature Reviews Drug Discovery ReviewOpen access 4 Dec 2020 7,854
3 Understanding biophysicochemical interactions at the nano–bio interface André E. Nel, Lutz Mädler, Darrell Velegol et al. · Nature Materials 14 Jun 2009 7,073
4 Principles of nanoparticle design for overcoming biological barriers to drug delivery Elvin Blanco, Haifa Shen, Mauro Ferrari · Nature Biotechnology Open access Sep 2015 6,967
5 Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications Sophie Laurent, Delphine Forge, Marc Port et al. · Chemical Reviews Review Jun 2008 6,788
All 100 most cited papers, with filters and sorting

Where is Nanoparticle-Based Drug Delivery research done?

The largest centres of Nanoparticle-Based Drug Delivery research in 2022-now are Beijing (China), Shanghai (China), Tehran (Iran) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Moga, Saugor and Tabriz.

Largest cities, 2022-now

  1. 1 BeijingChina 411 works
  2. 2 ShanghaiChina 358 works
  3. 3 TehranIran 285 works
  4. 4 GuangzhouChina 217 works
  5. 5 NanjingChina 211 works
  6. 6 HangzhouChina 190 works
  7. 7 ChengduChina 171 works
  8. 8 ChennaiIndia 150 works
  9. 9 MumbaiIndia 142 works
  10. 10 ShenyangChina 136 works

Where it is the local speciality

  1. MogaIN · 20.6 works38×
  2. SaugorIN · 24.6 works9.7×
  3. TabrizIR · 84.4 works9.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Nanoparticle-Based Drug Delivery than the world average.

See Nanoparticle-Based Drug Delivery on the map

Where is the best place to study Nanoparticle-Based Drug Delivery?

Among universities, judged by research, American University of Sharjah, Sichuan University and University of Macau score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.54%fractional works in this field (log) →share of work in the world top 10% →American University …Zabol UniversityUniversity of MacauSichuan University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1American University of SharjahUnited Arab Emirates 67.336.7%9.5×10 +80.2%
2Sichuan UniversityChina 63.018.2%4.0×107 -7.3%
3University of MacauChina 60.820.1%3.4×13 +47.4%
4Zabol UniversityIran 59.326.3%26.9×10 +274.1%
5Jilin UniversityChina 58.115.7%4.1×56 +35.8%
6Islamic Azad University, TehranIran 57.97.5%5.3×104 +20.9%
7King Khalid UniversitySaudi Arabia 57.915.5%4.5×20 +225.2%
8King Saud UniversitySaudi Arabia 57.09.4%3.9×45 +73.1%
9China Medical UniversityChina 56.315.5%7.8×38 +100.6%
10Mashhad University of Medical SciencesIran 56.110.5%16.0×43 +60.8%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Nanoparticle-Based Drug Delivery, country by country

Is Nanoparticle-Based Drug Delivery research growing?

Output in 2022-2025 was 15% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Nanoparticle-Based Drug Delivery.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nanoparticle-Based Drug Delivery as a percentage of every work published that year, 0.058% in 2024.

still counting0.025%0.050%0.075%Nanoparticle-Based Drug Delivery0.061% in 202519801990200020102020

Fractional works of Nanoparticle-Based Drug Delivery over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Nanoparticle-Based Drug Delivery9.7% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who leads research on drug delivery with nanoparticles?

By volume in 2022-now, Chinese Academy of Sciences publishes the most Nanoparticle-Based Drug Delivery research, followed by Sichuan University and Islamic Azad University, Tehran. By volume, China and India publish the most (4k and 2.3k works in 2022-now).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Nanoparticle-Based Drug Delivery. Posts are plain text and can be reported.